Patient Reported Outcomes/Metrics Program Trial (PROMPT)
Status
Conditions
Treatments
Details and patient eligibility
About
This is an observational study to investigate if it is feasible to recruit 100 patients receiving radiotherapy (RT) to metastatic disease to wear Hexoskin and if Hexoskin will facilitate the monitoring, detection and early treatment of RT-related side effects.
Full description
Radiotherapy is an important adjunct in the interdisciplinary care of the palliative patient population, providing the potential for improved quality of life and symptom control, often translating into improved well-being, function and mobility. Changes in pain and QOL are frequently measured subjectively using patient-reported questionnaires. Objective measures such as respiratory rate, pulse rate, activity level and sleep duration and quality, may complement the currently available tools. Such tools may lead to better evaluation of the effects of palliative RT with real-time detection of potential complications and toxicity and the acute need for analgesic adjustments that can result from successful palliative RT.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Planned to receive palliative radiotherapy for pain
- Known cancer diagnosis
- Able to wear Hexoskin Medical Shirt
- Ability to use and populate the mobile app (Zamplo) with or without assistance
- ECOG: 0-3
- Willing to provide a list of analgesic (pain relief) medication
- Willing to complete questionnaires
- Life expectancy of at least 3 months
Exclusion criteria
- Receiving whole brain radiotherapy
- Major cognitive or psychiatric impairments
- Pregnant women
- Allergies to: polyester, synthetic fibers
- Patients with pacemakers or implantable cardioverter-defibrillator (ICD)
- Patients on a Holter Monitor
Trial contacts and locations
Loading...
Central trial contact
Philip Wong
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal